Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

To evaluate the efficacy and toxicity of irinotecan (CPT-11) in combination with raltitrexed as first-line treatment of advanced colorectal cancer (CRC). A total of 91 previously untreated patients with advanced CRC and measurable disease were enrolled in this phase II study. The median age was 62 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Feliu, J, Salud, A, Escudero, P, López-Gómez, L, Pericay, C, Castañón, C, de Tejada, M R López, Rodríguez-García, J M, Martínez, M P, Martín, M Sanz, Sánchez, J J, Barón, M González
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409728/
https://www.ncbi.nlm.nih.gov/pubmed/15083176
http://dx.doi.org/10.1038/sj.bjc.6601713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409728/
https://www.ncbi.nlm.nih.gov/pubmed/15083176
http://dx.doi.org/10.1038/sj.bjc.6601713

Ejemplares similares